Advertisements

TransEnterix Inc. (TRXC) Stock Quote

Detailed Quote for TransEnterix Inc. (TRXC)
$ 3.47 r      0.39 (+12.66%) Volume: 21.38m 8:00 PM EDT Oct 20, 2017
After Hours:  $ 3.41   -0.06 (-1.73%) Volume: 205.31k 7:59 PM EDT Oct 20, 2017
Today 5d 1m 3m 1y more
Last Price
3.47
Change $
0.39
Change %
12.66%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
3.20
High
3.54
Low
3.03
Prev Close
3.08
Last Trade
10/20/17
Volume
21.38m
52 Wk Hi
5.00
52 Wk Low
0.449999988
Market Cap
515.42m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
148,536,356
EPS (TTM)
-0.469999998
PE Ratio
N/A
Exchange
NYSE American
News and Media for TransEnterix Inc. (TRXC)
Sector News | Topic News
News for TransEnterix Inc. (TRXC)
Fri, Oct 20, 2017
9:18 AM Premarket Gainers as of 9:05 am - SeekingAlpha
Thu, Oct 19, 2017
12:40 PM Midday Gainers / Losers - SeekingAlpha
Wed, Oct 18, 2017
9:21 AM Premarket Gainers as of 9:05 am - SeekingAlpha
Tue, Oct 17, 2017
12:45 PM Midday Gainers / Losers - SeekingAlpha
9:14 AM Premarket Gainers as of 9:05 am - SeekingAlpha
9:07 AM FDA OK of TransEnterix's Senhance triggers accelerated expiration of Series A Warrants; shares up 6% premarket - SeekingAlpha
7:20 AM Featured Company News - FDA Grants US 510(k) Clearance to TransEnterix's Senhance(TM) Surgical Robotic System - ACCESSWIRE IA
Mon, Oct 16, 2017
12:43 PM Midday Gainers / Losers - SeekingAlpha
9:27 AM Premarket Gainers as of 9:05 am - SeekingAlpha
Fri, Oct 13, 2017
5:00 PM TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic System - Business Wire
Mon, Oct 09, 2017
6:55 AM TransEnterix Announces Dismissal of Federal Securities Class Action - Business Wire
Mon, Sep 18, 2017
8:12 AM TransEnterix reports progress on Senhance FDA submission - SeekingAlpha
6:30 AM TransEnterix, Inc. Reports Progress on Senhance FDA Submission - Business Wire
Wed, Sep 13, 2017
12:49 PM Midday Gainers / Losers - SeekingAlpha
Tue, Sep 12, 2017
6:55 AM TransEnterix to Participate in Two Upcoming Healthcare Conferences - Business Wire
Thu, Aug 03, 2017
4:05 PM TransEnterix Announces First Senhance U.S. Innovation Center at Florida Hospital Orlando - Business Wire
Wed, Aug 02, 2017
10:37 PM TransEnterix's (TRXC) CEO Todd Pope on Q2 2017 Results - Earnings Call Transcript - SeekingAlpha
4:13 PM TransEnterix EPS in-line, beats on revenue - SeekingAlpha
4:05 PM TransEnterix, Inc. Reports Operating Results for the Second Quarter 2017 - Business Wire
10:41 AM Investor Network: TransEnterix, Inc. to Host Earnings Call - ACCESSWIRE
More News for TRXC >>

Tags for TransEnterix Inc.

Research stocks or mutual funds related to TransEnterix Inc. by keywords or tags. Find companies that have a similar focus to TRXC. The keywords below have been associated to TRXC by either user submission or electronic means.



 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2017 InvestorPoint.com All rights reserved.